▶ 調査レポート

世界の足&足首用デバイス市場(~2027):原因別、製品別、用途別、地域別

• 英文タイトル:Foot & Ankle Devices Market Research Report by Cause, Product, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが調査・発行した産業分析レポートです。世界の足&足首用デバイス市場(~2027):原因別、製品別、用途別、地域別 / Foot & Ankle Devices Market Research Report by Cause, Product, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 / MRC2303L001資料のイメージです。• レポートコード:MRC2303L001
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、242ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の本調査レポートでは、2021年に4,003.98百万ドルであった世界の足&足首用デバイス市場規模が2022年に4,359.53百万ドルとなり、2027年までに年平均9.13%拡大して6,765.11百万ドルに達すると予測されています。本書では、足&足首用デバイスの世界市場を対象に総合的に調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、原因別(糖尿病、神経学的障害、外傷)分析、製品別(ブレーシング&サポート、関節インプラント、整形外科固定用具、補綴物、軟部組織整形外科用デバイス)分析、用途別(外反母趾、槌状足指症、神経学的障害、変形性関節症、骨粗鬆症)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの構成でまとめております。なお、本書に掲載されている企業情報には、aap Implantate AG、Acumed, LLC、Advanced Orthopedic Solutions Inc、Arthrex, Inc.、Bioretec Ltd.、Colfax Corporation、CONMED Corporation、Extremity Medical, LLC、Fillauer LLC、Integra Lifesciences Corporationなどが含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の足&足首用デバイス市場規模:原因別
- 糖尿病における市場規模
- 神経学的障害における市場規模
- 外傷における市場規模
・世界の足&足首用デバイス市場規模:製品別
- ブレーシング&サポートの市場規模
- 関節インプラントの市場規模
- 整形外科固定用具の市場規模
- 補綴物の市場規模
- 軟部組織整形外科用デバイスの市場規模
・世界の足&足首用デバイス市場規模:用途別
- 外反母趾における市場規模
- 槌状足指症における市場規模
- 神経学的障害における市場規模
- 変形性関節症における市場規模
- 骨粗鬆症における市場規模
・世界の足&足首用デバイス市場規模:地域別
- 南北アメリカの足&足首用デバイス市場規模
アメリカの足&足首用デバイス市場規模
カナダの足&足首用デバイス市場規模
ブラジルの足&足首用デバイス市場規模
...
- アジア太平洋の足&足首用デバイス市場規模
日本の足&足首用デバイス市場規模
中国の足&足首用デバイス市場規模
インドの足&足首用デバイス市場規模
韓国の足&足首用デバイス市場規模
台湾の足&足首用デバイス市場規模
...
- ヨーロッパ/中東/アフリカの足&足首用デバイス市場規模
イギリスの足&足首用デバイス市場規模
ドイツの足&足首用デバイス市場規模
フランスの足&足首用デバイス市場規模
ロシアの足&足首用デバイス市場規模
...
- その他地域の足&足首用デバイス市場規模
・競争状況
・企業情報

The Global Foot & Ankle Devices Market size was estimated at USD 4,003.98 million in 2021 and expected to reach USD 4,359.53 million in 2022, and is projected to grow at a CAGR 9.13% to reach USD 6,765.11 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Foot & Ankle Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Cause, the market was studied across Diabetes, Neurological Disorders, and Trauma.

Based on Product, the market was studied across Bracing & Support, Joint Implants, Orthopedic Fixation, Prosthetics, and Soft Tissue Orthopedic Devices.

Based on Application, the market was studied across Bunions, Hammertoe, Neurological Disorders, Osteoarthritis, Osteoporosis, Rheumatoid Arthritis, and Trauma.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Foot & Ankle Devices market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Foot & Ankle Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Foot & Ankle Devices Market, including aap Implantate AG, Acumed, LLC, Advanced Orthopedic Solutions Inc, Arthrex, Inc., Bioretec Ltd., Colfax Corporation, CONMED Corporation, Extremity Medical, LLC, Fillauer LLC, Integra Lifesciences Corporation, Johnson & Johnson, Medartis AG, Olympus Corporation, Ortho Solutions UK Ltd., Ossur HF, Ottobock SE & Co. KGaA, Smith & Nephew PLC, Stryker Corporation, VILEX IN TENNESSEE, INC., Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Foot & Ankle Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Foot & Ankle Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Foot & Ankle Devices Market?
4. What is the competitive strategic window for opportunities in the Global Foot & Ankle Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Foot & Ankle Devices Market?
6. What is the market share of the leading vendors in the Global Foot & Ankle Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Foot & Ankle Devices Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing number of injuries by several sports activities and accidents
5.1.1.2. Rising incidence of orthopedic diseases pertinent to foot and ankle disorders
5.1.1.3. Increasing elderly population and prevalence of diseases such as osteoporosis
5.1.2. Restraints
5.1.2.1. Capital intensive foot and ankle devices
5.1.2.2. Concerns over metal sensitivity among patients
5.1.3. Opportunities
5.1.3.1. Emerging introduction and commercialization of new products such as 3D-printed implants
5.1.3.2. Ongoing demand for ankle prosthetics with advanced devices such as hydraulic and pneumatic feet
5.1.4. Challenges
5.1.4.1. Excise tax on medical devices and availability of alternate treatments
5.2. Cumulative Impact of COVID-19

6. Foot & Ankle Devices Market, by Cause
6.1. Introduction
6.2. Diabetes
6.3. Neurological Disorders
6.4. Trauma

7. Foot & Ankle Devices Market, by Product
7.1. Introduction
7.2. Bracing & Support
7.3. Joint Implants
7.4. Orthopedic Fixation
7.5. Prosthetics
7.6. Soft Tissue Orthopedic Devices

8. Foot & Ankle Devices Market, by Application
8.1. Introduction
8.2. Bunions
8.3. Hammertoe
8.4. Neurological Disorders
8.5. Osteoarthritis
8.6. Osteoporosis
8.7. Rheumatoid Arthritis
8.8. Trauma

9. Americas Foot & Ankle Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Foot & Ankle Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Foot & Ankle Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. aap Implantate AG
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Acumed, LLC
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Advanced Orthopedic Solutions Inc
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Arthrex, Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Bioretec Ltd.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Colfax Corporation
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. CONMED Corporation
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Extremity Medical, LLC
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Fillauer LLC
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Integra Lifesciences Corporation
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Johnson & Johnson
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Medartis AG
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Olympus Corporation
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Ortho Solutions UK Ltd.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Ossur HF
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Ottobock SE & Co. KGaA
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Smith & Nephew PLC
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Stryker Corporation
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. VILEX IN TENNESSEE, INC.
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Wright Medical Group N.V.
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Zimmer Biomet Holdings, Inc.
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing